Sign in
DBVT Stock Price, Chart, Stats & News
DBV Technologies S.A.
Save
DBV Technologies S.A. (DBVT) does not currently pay a dividend.
340.17M
Market cap
–
Current P/E
–
Forward P/E
DBVT chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 3.38% |
ROA | -63.03% |
ROE | -189.64% |
D/E | 0.13x |
Interest coverage ratio | -137.00x |
DBVT valuation
P/E | – |
P/S | – |
P/B | 4.54x |
P/CF | -6.30x |
P/FCF | -3.93x |
P/OCF | -6.30x |
PEG | -6.03x |
EV multiple | -4.85x |
About
DBV Technologies S. A., a biopharmaceutical firm based in Montrouge, France, operates at the clinical stage, focusing on the research and development of epicutaneous immunotherapy solutions. Its flagship product, Viaskin Peanut, has completed Phase III clinical trials as an immunotherapy for peanut allergies in children aged 4 to 11, adolescents, and adults.
Similar securities
Based on sector and market capitalization
Report issue